B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MU-TYPE

MOLECULAR TARGET

Mu-type opioid receptor (human)

UniProt: P3537265 compounds

MU-TYPE (Mu-type opioid receptor (human)) is targeted by 65 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MU-TYPE

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Morphine2.208
2Fentanyl2.087
3Astemizole Antihistamine drug now withdrawn from1.795
4Naloxone1.795
5Domperidone1.614
6Quetiapine Fumarate1.393
7Cinnarizine1.393
8Clotrimazole1.393
9Flunarizine Flunarizine is1.393
10Levorphanol1.393
11Promethazine1.393
12Reserpine1.393
13Amoxapine1.102
14Carvedilol1.102
15cinacalcet1.102
16Codeine1.102
17Disulfiram1.102
18Econazole1.102
19hydrocodone1.102
20Meperidine1.102
21Miconazole1.102
22Nalbuphine1.102
23oxatomide [Supplementary Concept] structure;1.102
24Tamsulosin1.102
25Sertraline0.691
26Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent0.691
27Aripiprazole0.691
28Benzethonium Bactericidal cationic quaternary ammonium surfactant used as0.691
29Bromocriptine0.691
30Butorphanol0.691
31candesartan cilexetil [Supplementary Concept]0.691
32Caspofungin0.691
33Danazol0.691
34Dequalinium0.691
35Dextromethorphan Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of0.691
36Dihydroergotamine0.691
37Dimethindene0.691
38Emetine0.691
39Physostigmine0.691
40Estrone0.691
41ethopropazine0.691
42Fluspirilene0.691
43Guanabenz0.691
44Hexachlorophene0.691
45Labetalol0.691
46Levallorphan0.691
47Loratadine0.691
48Loxapine0.691
49Meptazinol0.691
50Metergoline0.691

Showing top 50 of 65 compounds. Use the BiohacksAI search to explore all MU-TYPE modulators.

About MU-TYPE as a Drug Target

MU-TYPE (Mu-type opioid receptor (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 65 compounds with documented MU-TYPE interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MU-TYPE inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.